Ying Liu
Tianjin University of Traditional Chinese Medicine(CN)Hubei University of Medicine(CN)Shandong University of Traditional Chinese Medicine(CN)Shandong University(CN)Hubei University of Chinese Medicine(CN)Tianjin Huanhu Hospital(CN)Jiangxi Normal University(CN)Tianjin Medical University(CN)Hubei University(CN)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Advances in Cucurbitaceae Research
Most-Cited Works
- → LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a(2019)141 cited
- → miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease(2013)92 cited
- → Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy(2016)91 cited
- → Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer(2020)80 cited
- → Hepatoprotection and hepatotoxicity of Heshouwu, a Chinese medicinal herb: Context of the paradoxical effect(2016)77 cited
- → IRF6 Is Directly Regulated by ZEB1 and ELF3, and Predicts a Favorable Prognosis in Gastric Cancer(2019)70 cited